Cardiovascular
Micro Medical completes enrollment for stent pivotal trial
Micro Medical has completed enrolment for a US pivotal clinical study evaluating the safety and effectiveness of its MicroStent system…
Bioxodes enrols first patient in Phase IIa ischemic stroke trial
Belgium-based Bioxodes has enrolled the first patient in its Phase IIa study investigating a pipeline candidate Ir-CPI for ischemic stroke.…
AstraZeneca to halt Phase III hyperkalaemia trials of Lokelma
AstraZeneca has announced plans for the discontinuation of two Phase III clinical trials of Lokelma (sodium zirconium cyclosilicate) being analysed…
BiVACOR wins IDE to start first-in-human study for artificial heart
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to BiVACOR’s total artificial heart (BTAH),…
Pipeline Moves: Approval prospects drop for Bayer’s cardiovascular drug after Phase III termination
This week on Pipeline Moves, we kick off by looking at Phase III trial terminations by Bayer and Johnson &…
Post hoc analysis of SCORED trial sheds positive light on Inpefa for heart failure
At this year’s American Heart Association Scientific Session, positive results were presented from Lexicon Pharmaceuticals’s SCORED analysis of Inpefa (sotagliflozin),…
Surmodics reveals two-year data from drug-coated balloon trial
Surmodics’s drug-coated balloon met primary safety and efficacy endpoints in a first-in-human study for the treatment of occlusive disease of…
Pipeline Moves: Prospects drop after Phase III ovarian cancer trial failure
This week on Pipeline Moves, we kickoff by looking at two Phase III trials in oncology and kidney disease that…
Acorai wins €2.3m grant to help fund trial for heart monitoring device
Cardiology start-up Acorai has secured a €2.3m ($2.46m) grant with a follow-on €10m ($10.70m) investment from the European Innovation Council…
ResoTher Pharma given grant for myocardial infarction drug trial
The European Innovation Council (EIC) has given €2.5m ($2.67m) to Danish biopharmaceutical company ResoTher Pharma to advance the development of its lead…
